Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 8,203 |
|
|||||
| News | - | ||||||
| Day High | 5.68 | Low High |
|||||
| Day Low | 5.4701 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Foghorn Therapeutics Inc | FHTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.06 | -1.05% | 5.67 | 11:31:27 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 5.57 | 5.4701 | 5.68 | 5.73 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 137 | 8,203 | US$ 5.58 | US$ 45,799 | - | 2.70 - 9.97 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:25:53 | 18 | US$ 5.68 | USD |
Foghorn Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 241.35M | 42.57M | - | 34.16M | -98.43M | -2.31 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Foghorn Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/07/2024 | 06:11 | Edgar (US Regulatory) | Form 8-K - Current report |
| 3/07/2024 | 06:09 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
| 2/08/2024 | 06:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/25/2024 | 15:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 15:03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 15:03 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 15:02 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/25/2024 | 15:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 1/17/2024 | 15:09 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/08/2024 | 06:04 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/03/2024 | 15:18 | Edgar (US Regulatory) | Form 8-K - Current report |
| 11/27/2023 | 18:01 | PR Newswire (US) | Flagship Pioneering Marks Official Opening of UK Hub with.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical FHTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.20 | 5.90 | 4.80 | 5.28 | 51,534 | 0.47 | 9.04% |
| 1 Month | 6.81 | 8.05 | 4.80 | 6.33 | 76,892 | -1.14 | -16.74% |
| 3 Months | 2.82 | 8.44 | 2.81 | 6.03 | 149,343 | 2.85 | 101.06% |
| 6 Months | 3.42 | 8.44 | 2.70 | 5.26 | 128,586 | 2.25 | 65.79% |
| 1 Year | 6.67 | 9.97 | 2.70 | 5.79 | 107,287 | -1.00 | -14.99% |
| 3 Years | 10.51 | 24.34 | 2.70 | 11.98 | 143,770 | -4.84 | -46.05% |
| 5 Years | 18.12 | 28.265 | 2.70 | 12.75 | 141,306 | -12.45 | -68.71% |
Foghorn Therapeutics Description
| Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors. |
